Literature DB >> 8845447

Molecular detection of human cytomegalovirus and determination of genotypic ganciclovir resistance in clinical specimens.

S A Spector1, K Hsia, D Wolf, M Shinkai, I Smith.   

Abstract

The data presented in this article demonstrate how the polymerase chain reaction (PCR) can be used to detect human cytomegalovirus (HCMV) DNA in the plasma and cerebrospinal fluid (CSF) of infected individuals. Detection of HCMV DNA in plasma of transplant recipients and persons infected with human immunodeficiency virus identifies people with acute visceral disease and those at highest risk for development of HCMV disease. The detection of HCMV DNA in CSF is of particular help in identifying persons with HCMV-related central nervous system disease. In addition, specific mutations within the UL97 region, which encodes for a HCMV protein kinase, have been found to confer ganciclovir resistance and can be detected in plasma and CSF by direct sequencing of PCR products. These data will help provide tools for clinicians to better diagnose, manage, and treat persons with HCMV disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8845447     DOI: 10.1093/clinids/21.supplement_2.s170

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  12 in total

1.  Comparative quantitation of cytomegalovirus (CMV) DNA in solid organ transplant recipients with CMV infection by using two high-throughput automated systems.

Authors:  R R Razonable; R A Brown; M J Espy; A Rivero; W Kremers; J Wilson; C Groettum; T F Smith; C V Paya
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

2.  Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients.

Authors:  A M Caliendo; K St George; S Y Kao; J Allega; B H Tan; R LaFontaine; L Bui; C R Rinaldo
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  Recombinant phenotyping of cytomegalovirus UL97 kinase sequence variants for ganciclovir resistance.

Authors:  Sunwen Chou
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.191

4.  Cytomegalovirus retinitis and the acquired immunodeficiency syndrome--bench to bedside: LXVII Edward Jackson Memorial Lecture.

Authors:  Douglas A Jabs
Journal:  Am J Ophthalmol       Date:  2010-12-18       Impact factor: 5.258

5.  Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients.

Authors:  Adriana Weinberg; Debra Schissel; Roger Giller
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

6.  Quantification of cytomegalovirus DNA in peripheral blood leukocytes by a branched-DNA signal amplification assay.

Authors:  D N Chernoff; R C Miner; B S Hoo; L P Shen; R J Kelso; D Jekic-McMullen; J P Lalezari; S Chou; W L Drew; J A Kolberg
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

Review 7.  Molecular methods for diagnosis of viral encephalitis.

Authors:  Roberta L Debiasi; Kenneth L Tyler
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Rapid detection of human cytomegalovirus UL97 and UL54 mutations directly from patient samples.

Authors:  Ruth Hall Sedlak; Jared Castor; Susan M Butler-Wu; Elaine Chan; Linda Cook; Ajit P Limaye; Keith R Jerome
Journal:  J Clin Microbiol       Date:  2013-05-15       Impact factor: 5.948

9.  Rapid detection directly from patient serum samples of human cytomegalovirus UL97 mutations conferring ganciclovir resistance.

Authors:  Jared Castor; Linda Cook; Lawrence Corey; Keith R Jerome
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

10.  Detection of ganciclovir resistance in patients with AIDS and cytomegalovirus retinitis: correlation of genotypic methods with viral phenotype and clinical outcome.

Authors:  Douglas A Jabs; Barbara K Martin; Michelle O Ricks; Michael S Forman
Journal:  J Infect Dis       Date:  2006-05-10       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.